β 2-Microglobulin Kinetics in Maintenance Hemodialysis: A Comparison of Conventional and High-Flux Dialyzers and the Effects of Dialyzer Reuse

American Journal of Kidney Diseases

Volumn 13, Issue 5, 1989, Pages 390-395

  DiRaimondo, Carol R ^a   Pollak, Victor E ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

amyloidosis; dialyzer reuse; hemodialysis; high flux hemodialysis; 2 Microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN;

AMYLOIDOSIS; ARTIFICIAL KIDNEY; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; FEMALE; HEMODIALYSIS; HUMAN; MALE; NEUTROPENIA;

EID: 0024399363     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(89)80022-8     Document Type: Article

References (33)

1. Beta-2 microglobulin is an amyloidogenic protein in man
2. A new form of amyloid protein associated with chronic hemodialysis was identified as beta-2 microglobulin
3. Polymerization of intact beta-2 microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis
4. β2M amyloidosis
5. Synovial amyloidosis in patients undergoing long-term hemodialysis
6. Erosive azotemic osteoarthropathy: Possible role of amyloidosis
7. Amyloid arthropathy in patients undergoing periodical haemodialysis for chronic renal failure: A new complication
8. Pathologic fractures associated with idiopathic amyloidosis of bone in chronic hemodialysis patients
9. Carpal tunnel syndrome with cystic bone lesions secondary to amyloidosis in chronic hemodialysis patients
10. Tumoral amyloidosis of bone of beta-2 microglobulin origin in association with long-term hemodialysis: A new type of amyloid disease
11. Carpal tunnel syndrome caused by amyloid containing beta-2 microglobulin: A new amyloid and a complication of long term haemodialysis
12. Synovial amyloidosis of beta-2 microglobulin type in patients undergoing long-term hemodialysis
13. Beta-2 microglobulin serum levels in patients on long-term dialysis
14. Possible role of dialysis membrane characteristics in amyloid osteoarthropathy
15. Carpal tunnel syndrome and type of dialysis membrane used in patients undergoing long-term hemodialysis
16. Haemodialysis membranes, serum beta-2 microglobulin, and dialysis amyloidosis
17. Effect of reprocessing dialyzers on serum beta-2 microglobulin in hemodialysis patients
18. Evaluation of new synthetic membranes for high-flux hemodialysis
19. Beta-2 microglobulin and hemodialysis membranes: In vivo and in vitro studies
20. Behavior of beta-2 microglobulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration, and continuous ambulatory peritoneal dialysis (CAPD)
21. No change in corrected beta-2 microglobulin concentration after cuprophane haemodialysis
22. Beta-2 microglobulin and haemodialysis
23. Beta-2 microglobulin and haemodialysis
24. Beta-2 microglobulin and haemodialysis
25. Beta-2 microglobulin kinetics during haemodialysis and haemofiltration
26. Determinants of plasma beta-2 microglobulin concentration: possible relation to membrane biocompatibility
27. A prospective study of reduced dialysis
28. Effect of first and subsequent use of hemodialyzers on patient well-being: The rise and fall of a syndrome associated with new dialyzer use
29. Serum beta-2 microglobulin in hemodialysed patients
30. Plasma beta-2 microglobulin turnover in renal insufficiency
31. Bicarbonate hemodialysis: Influence on plasma refilling and hemodynamic stability
32. Permeability and secondary membrane formation of a high flux polysulfone hemofilter
33. Beta-2 microglobulin-associated amyloidosis in chronic haemodialysis patients